Hospice News July 17, 2024
Jim Parker

The oncology-focused value-based enabler Thyme Care has completed a $95 million funding round that includes $55 million in equity funding.

The company offers palliative care in addition to other services. In May, Thyme Care launched a new palliative care telehealth offering, branded as Enhanced Supportive Care.

Thyme Care will use the new infusion of investment dollars to expand to new geographies and build new partnerships with oncologists, primary care practices and health plans, according to a press release.

“Our latest funding is a testament to the dedication and expertise of our incredible team, whose relentless efforts drive our mission to transform the cancer care experience forward,” said Robin Shah, Thyme Care co-founder and CEO, in a statement. “We are profoundly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Payment Models, Trends, Value Based
Long-Term Benefits Show the Value of Upfront Investments in Value-Based Care
Lessons from the NAACOS 2024 Fall Conference
Evolving Markets, Innovative Solutions: The Rise of Specialty VBC
A value-based care 'enabler' explains its successful model
Q&A: Pharmacy’s Evolving Relationship with Value-Based Care

Share This Article